Publications by authors named "Neil Lineberry"

Claim this Profile
P
Phase 1b Study of Dazostinag Plus Pembrolizumab After Hypofractionated Radiotherapy in Patients With Select Advanced Solid Tumors.
Benjamin T Cooper, Wade T Iams, David B Page, Yuan Yuan, Naamit K Gerber, Neil Lineberry

Cancer Res Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Situ Proinflammatory Effects of Dazostinag Alone or with Chemotherapy on the Tumor Microenvironment of Patients with Head and Neck Squamous Cell Carcinoma.
Richard C Gregory, Neil Lineberry, Alex Parent, Karthik Rajasekaran, Thomas J Ow

Cancer Res Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody-Drug Conjugate TAK-500.
Vicky A Appleman, Atsushi Matsuda, Michelle L Ganno, Dong Mei Zhang, Emily Rosentrater, Neil Lineberry

Cancer Immunol Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asia-Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo.
Karthik Venkatakrishnan, Neeraj Gupta, Patrick F Smith, Tiffany Lin, Neil Lineberry

Clin Pharmacol Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic Database.
Yanyu Wu, Yu Yin, Victoria Crossland, Sylvie Vincent, Paul K Paik, Neil Lineberry

Clin Lung Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of Tumor-Cell STING Primes NK-Cell Therapy.
Erik H Knelson, Elena V Ivanova, Mubin Tarannum, Marco Campisi, Patrick H Lizotte, Neil Lineberry

Cancer Immunol Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in IBD Research: Novel Technologies.
Manish Dhyani, Nitin Joshi, Willem A Bemelman, Michael S Gee, Vijay Yajnik, Neil Lineberry

Inflamm Bowel Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective.
Neil Lineberry, Jesse A Berlin, Bernadette Mansi, Susan Glasser, Michael Berkwits

BMJ· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications.
Ana Marušić, Darko Hren, Bernadette Mansi, Neil Lineberry, Ananya Bhattacharya

BMC Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Market watch: pricing strategies for emerging markets.
Neil Lineberry, Eric Snyder, Seema Gunda

Nat Rev Drug Discov· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes.
Laura E Edgington, Alicia B Berger, Galia Blum, Victoria E Albrow, Margot G Paulick, Neil Lineberry

Nat Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.
Jack T Lin, Neil B Lineberry, Michael G Kattah, Leon L Su, Paul J Utz

J Immunol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The single subunit transmembrane E3 ligase gene related to anergy in lymphocytes (GRAIL) captures and then ubiquitinates transmembrane proteins across the cell membrane.
Neil Lineberry, Leon Su, Luis Soares, C Garrison Fathman

J Biol Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting edge: The transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy.
Neil B Lineberry, Leon L Su, Jack T Lin, Greg P Coffey, Christine M Seroogy

J Immunol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanisms of CD4+ T-cell anergy.
C Garrison Fathman, Neil B Lineberry

Nat Rev Immunol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes.
Leon Su, Neil Lineberry, Yul Huh, Luis Soares, C Garrison Fathman

J Immunol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell anergy: where it's LAT.
Neil Lineberry, C Garrison Fathman

Immunity· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYLD: deubiquitination-induced TCR signaling.
Neil Lineberry, C Garrison Fathman

Nat Immunol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis